- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06045884
FNB in Meniscal Tear Under GA
September 20, 2023 updated by: Jung-Taek Hwang, Chuncheon Sacred Heart Hospital
Effects of Sono-guided Femoral Nerve Block in Arthroscopic Surgery for Meniscal Tear Under General Anesthesia: A Randomized Controlled Trial
The investigators will compare the results of sono-guided femoral nerve block in arthroscopic surgery for meniscal tear under general anesthesia
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
This study is a randomized controlled trial of 100 patients, who underwent history taking, physical examinations, x-rays, and MRI or ultrasonography, and were diagnosed with meniscal tear from september 2023 to august 2028.
The 100 patients will be assigned to Group I (with femoral nerve block) or Group II (without femoral nerve block) under double-blinded randomization.
The randomization will be performed by an independent nurse using a computerized random sequence generator.
The operators who participated in the procedure will be blinded to the participant's information.
Both group will undergo general anesthesia for arthroscopic meniscal surgery.
After anesthesia, sono-guided femoral nerve block will be performed.
The injection for group1 is 20 mL ropivacaine and for groupII is 20 mL 0.9% saline.
A visual analog scale (VAS) for pain will be recorded 1, 3, 6, 12, 18, 24, 36, 48 hours after the operation.
VAS scores range from 0 to 10, with 0 being no pain and 10 being the most severe pain ever experienced.
Injection with ultrasonography will be performed by a single anesthesiologist.
3 orthopedic surgeons will perform the surgery.
Study Type
Interventional
Enrollment (Estimated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gangwon-do
-
Chuncheon, Gangwon-do, Korea, Republic of, 24253
- Chuncheon Sacred Heart Hospital
-
Principal Investigator:
- Jung-Taek Hwang, MD, PhD
-
Contact:
- Ho Jung Jung, MD
- Phone Number: 82 33 240 5198
- Email: hodge.jung@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- individuals who are scheduled to undergo meniscal surgery and must be received sufficient explanation about the research prior to surgery and have provided their informed consent to participate.
Exclusion Criteria:
- who require simultaneous surgery for concomitant cartilage injury, collateral ligament tear.
- who have previously undergone surgical treatment within the knee joint.
- who have declined to participate in the research.
- where medical, surgical, or anesthetic complications occurred during surgery.
- other cases deemed necessary by the researchers.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: FNB
sono-guided femoral nerve injection with 20ml ropivacaine
|
After general anesthesia, patients will be injected around femoral nerve using ultrasonography.
After general anesthesia, patients will be injected 20ml ropivacaine around femoral nerve.
|
Placebo Comparator: No FNB
sono-guided femoral nerve injection with 20ml 0.9% saline
|
After general anesthesia, patients will be injected around femoral nerve using ultrasonography.
After general anesthesia, patients will be injected 20ml 0.9% saline around femoral nerve.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
postoperative pain after 24hours
Time Frame: 24hours
|
VAS (Visual analog scale) measured 24 hours after operation
|
24hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
postoperative pain after 1, 3, 6, 12, 18, 48 hours
Time Frame: 1, 3, 6, 12, 18, 48 hours
|
VAS (Visual analog scale) measured 1, 3, 6, 12, 18, 48 hours after operation
|
1, 3, 6, 12, 18, 48 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
September 18, 2023
Primary Completion (Estimated)
September 18, 2026
Study Completion (Estimated)
September 18, 2026
Study Registration Dates
First Submitted
September 13, 2023
First Submitted That Met QC Criteria
September 19, 2023
First Posted (Actual)
September 21, 2023
Study Record Updates
Last Update Posted (Actual)
September 22, 2023
Last Update Submitted That Met QC Criteria
September 20, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023-07-019-001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Meniscus Tear
-
Artromedical Konrad Malinowski ClinicRecruitingMeniscus; Degeneration | Meniscus Lesion | Meniscus Tear | Meniscus DisorderPoland
-
Austin V StoneNot yet recruitingMeniscus Lesion | Meniscus Tear | Meniscus Disorder | Meniscus; DerangementUnited States
-
Ataturk UniversityCompletedMeniscus Lesion | Meniscus TearTurkey
-
Smith & Nephew, Inc.Active, not recruitingMeniscus Tear | Retention; MeniscusUnited States
-
Mastelli S.r.lLatis S.r.l.RecruitingMeniscus Lesion | Meniscus TearBelgium, Italy
-
Zimmer BiometRecruitingMeniscus Lesion | Meniscus Tear, TibialUnited States, France, Germany, Japan
-
Smith & Nephew, Inc.CompletedMeniscal Tear | Meniscus TearUnited States
-
Rush University Medical CenterInternational Society of Arthroscopy, Knee Surgery and Orthopaedic Sports...RecruitingMeniscus Tear, TibialUnited States
-
Istanbul Physical Medicine Rehabilitation Training...Not yet recruitingMeniscus TearTurkey
-
NYU Langone HealthNot yet recruiting
Clinical Trials on Sono-guided injection
-
Tri-Service General HospitalEusol Biotech Co., Ltd.Not yet recruitingCarpal Tunnel Syndrome
-
Tri-Service General HospitalCompleted
-
Tri-Service General HospitalCompletedCarpal Tunnel SyndromeTaiwan
-
Chuncheon Sacred Heart HospitalNot yet recruiting
-
Chuncheon Sacred Heart HospitalNot yet recruitingAnterior Cruciate Ligament Rupture | Femoral Nerve BlockKorea, Republic of
-
Chuncheon Sacred Heart HospitalNot yet recruitingAnterior Cruciate Ligament Rupture | Femoral Nerve BlockKorea, Republic of
-
Seoul National University HospitalCompleted
-
The Catholic University of KoreaUnknown
-
Yonsei UniversityWithdrawnCardiac SurgeryKorea, Republic of
-
Yonsei UniversityUnknownPatients Undergoing SurgeryKorea, Republic of